Agency plans to consolidate oversight of drugs and biologics and revise program for ensuring high quality pharmaceutical manufacturing
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Big Beautiful Bill Reduces Drugs Eligible for Price Negotiations
Read More
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
Listen
Updated: FDA Approves Leqembi Autoinjector for Maintenance Dosing in Alzheimer’s
Teva Launches First Generic GLP-1 Drug for Obesity
Novo Nordisk Teams with Form Health, 9amHealth for Obesity Care
Lilly’s Oral GLP-1 Meets Endpoints in Phase 3 Trial